Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIUC): A multicenter phase 2 trial.

Minas P. Economides, Scot A. Niglio, Tsivia Hochman et al.|Journal of Clinical Oncology|2023

Cited by 8